Average Co-Inventor Count = 5.61
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (16 from 3,681 patents)
2. Macrogenics, Inc. (3 from 130 patents)
3. Innate Pharma (2 from 66 patents)
4. Incyte Corporation (1 from 665 patents)
19 patents:
1. 12448448 - Anti-PD-1 antibodies and uses thereof
2. 11174315 - Combination therapy for the treatment of cancer
3. 11078279 - Combination therapy for the treatment of cancer
4. 10688180 - Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer
5. 10604575 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
6. 10584170 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
7. 10577423 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
8. 10323093 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
9. 10323092 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
10. 10316090 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
11. 10316091 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
12. 10308714 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
13. 10266594 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
14. 10266595 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
15. 10266596 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling